Huang Jane (CIK 1683913) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-07). Recent activity: Buy PRLD (9,375 shares), Sell PRLD (3,355 shares), Buy PRLD (9,375 shares), Sell PRLD (3,355 shares), Buy PRLD (9,375 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-07 | Prelude Therapeutics Inc (PRLD) | President, CMO | Buy | 9,375 | $0 |
| 2025-10-07 | Prelude Therapeutics Inc (PRLD) | President, CMO | Sell | 3,355 | $4,932 |
| 2025-07-08 | Prelude Therapeutics Inc (PRLD) | President, CMO | Buy | 9,375 | $0 |
| 2025-07-08 | Prelude Therapeutics Inc (PRLD) | President, CMO | Sell | 3,355 | $2,650 |
| 2025-04-07 | Prelude Therapeutics Inc (PRLD) | President, CMO | Buy | 9,375 | $0 |
| 2025-04-07 | Prelude Therapeutics Inc (PRLD) | President, CMO | Sell | 3,355 | $2,281 |
Source: SEC Form 4 filings · as of 2025-10-07